Pay in 4 interest-free payments of $22.25 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
and ovarian cancers
Clinical trials show decreased anxiety symptoms
Sequence: Met-Arg-Trp-Gln-Glu-Met-Gly-Tyr-Ile-Phe-Tyr-Pro-Arg-Lys-Leu-Arg (MRWQEMGYIFYPRKLR)
Molecular Formula: C₁₈₈H₂₉₃N₅₃O₄₄S
Bone Density Research: In GH-deficient and ovariectomized rat models
SLU-PP-322 (5mg) and ovarian cancersSLU PP 322 Product Description Overview SLU PP 322 is a synthetic small molecule engineered to function as a potent, non selective agonist of the estrogen related receptors (ERRs), with a notable affinity for ERR. Designed for cutting edge research in metabolic health and exercise mimetics, SLU PP 322 activates ERR pathways without eliciting estrogenic effects, positioning it as an invaluable asset for studying cellular energy regulation,
US$ 29.99
US$ 11500.00
US$ 24.00
US$ 55.00
US$ 29.99
US$ 15.95
US$ 12.00
US$ 250.00
US$ 447.50
